![Cooperman Barnabas Medical Center Partners with The Mall at Short Hills to Celebrate Breast Cancer Awareness Month Cooperman Barnabas Medical Center Partners with The Mall at Short Hills to Celebrate Breast Cancer Awareness Month](https://www.rwjbh.org/images/Breast-Cancer-End-Card.png)
Cooperman Barnabas Medical Center Partners with The Mall at Short Hills to Celebrate Breast Cancer Awareness Month
![Pluvicto: Men with advanced prostate cancer going without life-prolonging medication amid shortage | CNN Pluvicto: Men with advanced prostate cancer going without life-prolonging medication amid shortage | CNN](https://media.cnn.com/api/v1/images/stellar/prod/230321111612-novartis-factory-file-102715.jpg?c=original)
Pluvicto: Men with advanced prostate cancer going without life-prolonging medication amid shortage | CNN
![Summit Medical Group and MD Anderson Cancer Center Officially Launch Partnership to Bring Premier Cancer Treatment Advances to Northern New Jersey | Mountainside, NJ News TAPinto Summit Medical Group and MD Anderson Cancer Center Officially Launch Partnership to Bring Premier Cancer Treatment Advances to Northern New Jersey | Mountainside, NJ News TAPinto](https://tapinto-production.s3.amazonaws.com/uploads/photos/sm/best_crop_6d9c58b71c81bc4348d9_LeBenger_J_20_pp_med.jpg?id=4373893)
Summit Medical Group and MD Anderson Cancer Center Officially Launch Partnership to Bring Premier Cancer Treatment Advances to Northern New Jersey | Mountainside, NJ News TAPinto
![Atlantic Health System Cancer Care physicians are 1st in state to perform new treatment for prostate cancer | ROI-NJ Atlantic Health System Cancer Care physicians are 1st in state to perform new treatment for prostate cancer | ROI-NJ](https://images.roi-nj.com/wp-content/uploads/2022/08/Photo-A-Prostate-Image-1.jpg)
Atlantic Health System Cancer Care physicians are 1st in state to perform new treatment for prostate cancer | ROI-NJ
![Hackensack Meridian Mountainside Medical Center becomes first New Jersey hospital approved to treat prostate cancer in adults using Novartis Pluvicto™ | Hackensack Meridian Mountainside Medical Center Hackensack Meridian Mountainside Medical Center becomes first New Jersey hospital approved to treat prostate cancer in adults using Novartis Pluvicto™ | Hackensack Meridian Mountainside Medical Center](https://mountainsidehosp.com/sites/default/files/styles/blog_full_size/public/Brett%20Lewis%2C%20M.D.%2C%20Ph.D.%2C%20radiation%20oncology.png?itok=VBkmwJsG)
Hackensack Meridian Mountainside Medical Center becomes first New Jersey hospital approved to treat prostate cancer in adults using Novartis Pluvicto™ | Hackensack Meridian Mountainside Medical Center
![An Expert Commentary on the Patient Profile and Considerations for Treatment and Management of Prostate Cancer An Expert Commentary on the Patient Profile and Considerations for Treatment and Management of Prostate Cancer](https://cf-images.us-east-1.prod.boltdns.net/v1/jit/10203567001/043fa238-ef66-48c2-86eb-300023f484f7/main/1280x720/2m533ms/match/image.jpg)
An Expert Commentary on the Patient Profile and Considerations for Treatment and Management of Prostate Cancer
![Advancements in Prostate Cancer Treatments are Providing Better Outcomes for Men | Rutgers Cancer Institute of New Jersey Advancements in Prostate Cancer Treatments are Providing Better Outcomes for Men | Rutgers Cancer Institute of New Jersey](https://cinj.org/sites/cinj/files/inline/images/AdobeStock_300375478.jpeg)
Advancements in Prostate Cancer Treatments are Providing Better Outcomes for Men | Rutgers Cancer Institute of New Jersey
![ProCure Proton Therapy Center New Jersey Celebrates Five-Year Cancer-Free Milestone for Prostate Cancer Patients | Imaging Technology News ProCure Proton Therapy Center New Jersey Celebrates Five-Year Cancer-Free Milestone for Prostate Cancer Patients | Imaging Technology News](http://media.nj.com/procure_proton_therapy_center/photo/2017/06/09/ManInChargeInfographic2016.jpg)
ProCure Proton Therapy Center New Jersey Celebrates Five-Year Cancer-Free Milestone for Prostate Cancer Patients | Imaging Technology News
![Testicular cancer: men most at risk could be identified using new gene group | Cancer research | The Guardian Testicular cancer: men most at risk could be identified using new gene group | Cancer research | The Guardian](https://i.guim.co.uk/img/media/8048332867a80b922ced8d5f702231fd31b96116/0_0_2307_1384/master/2307.jpg?width=1200&height=1200&quality=85&auto=format&fit=crop&s=3c7bf6b35bdee65a42823a832e1bb619)